Read at al evaluated the significance of comorbidity when evaluating a patient with cancer. Sometimes comorbidity is significant and sometimes it is not. The authors are from the University of California in San Diego and Washington University.
Patient selection: presence of cancer
Cancer Status |
Significance of Comorbidity on Overall Survival |
advanced stage |
low |
active but not advanced stage |
intermediate |
in remission or indolent |
high |
Active or Aggressive Cancer |
Likelihood of Aggressive Management |
low comorbidity |
high |
intermediate comorbidity |
intermediate |
high comorbidity |
low |
Some comorbidities may impact management and its morbidity more than others:
(1) renal dysfunction (and drug dosage adjustment)
(2) liver disease (and drug metabolism)
(3) malnutrition
(4) heart disease and therapy with cardiotoxic effects
(5) hematopoietic dysfunction
(6) immunodeficiency (and a tumor impacted by immune response)
Purpose: To determine the significance of comorbidity in a patient with cancer.
Objective: comorbid conditions
ICD-10: C00-C14, C15-C26, C30-C39, C40-C41, C43-C44, C45-C49, C50-C50, C51-C58, C60-C63, C64-C68, C69-C72, C73-C75, C76-C80, C81-C96, C97-C97,